申请人:Merck Sharpe & Dohme Ltd.
公开号:US05405853A1
公开(公告)日:1995-04-11
A class of novel thiadiazoles, substituted on one of the ring carbon atoms with a non-aromatic azacyclic or azabicyclic ring system, and substituted on the other ring carbon atom with a substituent of low lipophilicity, or a hydrocarbon substituent; are potent muscarinic agonists, and have good CNS penetrability. The compounds are therefore useful in the treatment of neurological and mental illnesses, and are also of benefit in the treatment of severe painful conditions.
一类新型噻二唑类化合物,其中一个环上的碳原子被非芳香性氮杂环或氮杂双环系统取代,另一个环上的碳原子被低亲脂性取代基或烃基取代;这些化合物是有效的肌肉收缩素激动剂,并具有良好的中枢神经系统穿透性。因此,这些化合物在治疗神经和精神疾病方面具有用途,并且在治疗严重疼痛症状方面也具有益处。